William Riordan

725 total citations
11 papers, 601 citations indexed

About

William Riordan is a scholar working on Molecular Biology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, William Riordan has authored 11 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Hematology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in William Riordan's work include Ubiquitin and proteasome pathways (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Advanced Biosensing Techniques and Applications (2 papers). William Riordan is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Advanced Biosensing Techniques and Applications (2 papers). William Riordan collaborates with scholars based in United States, Germany and Canada. William Riordan's co-authors include Uri Piran, Thomas J. Sayers, William J. Murphy, Bruce R. Blazar, Jonathan S. Serody, Kai Sun, Angela Panoskaltsis‐Mortari, Isabel Barão, Matthew J. O’Shaughnessy and Christian Wysocki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Clinical Chemistry.

In The Last Decade

William Riordan

11 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Riordan United States 9 300 252 132 120 62 11 601
David W.C. Dekkers Netherlands 10 450 1.5× 131 0.5× 92 0.7× 154 1.3× 63 1.0× 11 866
Margaret S. Dordal United States 10 432 1.4× 153 0.6× 129 1.0× 215 1.8× 50 0.8× 12 822
Dominic Wall Australia 16 316 1.1× 130 0.5× 340 2.6× 140 1.2× 27 0.4× 39 729
P. Linssen Netherlands 18 540 1.8× 221 0.9× 283 2.1× 107 0.9× 57 0.9× 41 1.0k
Gloria Milani Italy 11 251 0.8× 95 0.4× 69 0.5× 70 0.6× 42 0.7× 16 420
Brigitte A. van Oirschot Netherlands 13 281 0.9× 151 0.6× 97 0.7× 48 0.4× 56 0.9× 42 616
Heriberto Bruzzoni‐Giovanelli France 15 570 1.9× 179 0.7× 281 2.1× 145 1.2× 80 1.3× 23 932
Hannah J. Lomax-Browne United Kingdom 11 312 1.0× 130 0.5× 106 0.8× 326 2.7× 55 0.9× 15 752
J Grabarek United States 10 236 0.8× 196 0.8× 41 0.3× 95 0.8× 36 0.6× 10 547
Andrea Ghelli Luserna di Rorà Italy 13 513 1.7× 115 0.5× 303 2.3× 76 0.6× 54 0.9× 38 735

Countries citing papers authored by William Riordan

Since Specialization
Citations

This map shows the geographic impact of William Riordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Riordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Riordan more than expected).

Fields of papers citing papers by William Riordan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Riordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Riordan. The network helps show where William Riordan may publish in the future.

Co-authorship network of co-authors of William Riordan

This figure shows the co-authorship network connecting the top 25 collaborators of William Riordan. A scholar is included among the top collaborators of William Riordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Riordan. William Riordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Reece, Donna, Dan M. Sullivan, Sagar Lonial, et al.. (2010). Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma. Cancer Chemotherapy and Pharmacology. 67(1). 57–67. 94 indexed citations
2.
Aghajanian, Carol, John A. Blessing, Kathleen M. Darcy, et al.. (2009). A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 115(2). 215–220. 49 indexed citations
3.
4.
Dees, Elizabeth Claire, Bert H. O’Neil, Celeste Lindley, et al.. (2008). A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors. Cancer Chemotherapy and Pharmacology. 63(1). 99–107. 21 indexed citations
5.
Hiroi, Toyoko, Clayton Deming, Haige Zhao, et al.. (2008). Bortezomib Improves Endothelial Thromboresistance Via Induction of KLF Transcription Factors.. Blood. 112(11). 1890–1890. 1 indexed citations
6.
Zhang, Li, Zheng Zhang, Xianshuang Liu, et al.. (2005). Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator. Thrombosis and Haemostasis. 95(1). 166–173. 48 indexed citations
7.
Sun, Kai, Angela Panoskaltsis‐Mortari, Matthew J. O’Shaughnessy, et al.. (2004). Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. Proceedings of the National Academy of Sciences. 101(21). 8120–8125. 197 indexed citations
8.
Piran, Uri, et al.. (1995). New noncompetitive immunoassays of small analytes. Clinical Chemistry. 41(7). 986–990. 8 indexed citations
9.
Piran, Uri, et al.. (1990). Effect of hapten heterology on thyroid hormone immunoassays. Journal of Immunological Methods. 133(2). 207–214. 13 indexed citations
10.
Piran, Uri & William Riordan. (1990). Dissociation rate constant of the biotin-streptavidin complex. Journal of Immunological Methods. 133(1). 141–143. 103 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David W.C. Dekkers Breakdown of academic impact, for papers by Margaret S. Dordal Breakdown of academic impact, for papers by Dominic Wall Breakdown of academic impact, for papers by P. Linssen Breakdown of academic impact, for papers by Gloria Milani Breakdown of academic impact, for papers by Brigitte A. van Oirschot Breakdown of academic impact, for papers by Heriberto Bruzzoni‐Giovanelli Breakdown of academic impact, for papers by Hannah J. Lomax-Browne Breakdown of academic impact, for papers by J Grabarek Breakdown of academic impact, for papers by Andrea Ghelli Luserna di Rorà
Rankless by CCL
2026